Taming the Supply Chain Data Beast - Webinar CD/Transcript
Taming the Supply Chain Data Beast: Compliance With the Drug Supply Chain Act Through Better Data Quality
On May 1 the Drug Supply Chain Security Act (DSCSA) went into effect for drug manufacturers, wholesalers and repackagers.
The Act requires that at every step of the drug supply chain, from factories to finished products to pharmacies, data from the supplier and the recipient must match perfectly or the entire batch will be quarantined until the discrepancy can be resolved. This raises a significant possibility of lost time and money for drug manufacturers.
The bottom line is you can no longer afford to have your supply chain disrupted by data problems.
GS1 has emerged as the solutions provider in this area. GS1 estimates between $2 and $5 billion can be saved annually across the drug industry through efficiency improvements. How much of that is yours?
Let GS1 US’s Senior VP Siobhan O’Bara, the recognized world leader in data quality, walk you through the steps necessary to not only ensure the quality of your supply chain data but also how to facilitate sharing that data with your partners.
In 90 minutes you’ll learn:
- How to completely comply with the 2015 DSCSA requirements. Plus, the even stricter 2017 and 2023 requirements.
- Tips and tricks to assure you have the correct data in the event of a recall. Recalls are costly, headache inducing and hurt your businesses’ reputation. Having the right data to eliminate these problems is crucial.
- Can you confidently say you can thwart counterfeit versions of your products entering the supply chain? You will be able to after this webinar.
- How GS1’s systems allow you to trace a single bottle all the way from the factory to a patient (one major manufacturer has collected data on over 4 million bottles!)
Disclaimer: The following presentation reflects the personal views and thoughts of the speaker. The content is solely for the purposes of discussion and illustration, and is not to be considered legal or regulatory advice. Speaker is providing this presentation, as is, as a service to interested parties. GS1 US shall not be liable for any consequential, special, indirect, incidental, liquidated, exemplary or punitive damages of any kind or nature whatsoever, or any lost income or profits, under any theory of liability, arising out of the use of this presentation or any content herein, even if advised of possibility of such loss or damage or if such loss or damage could have been reasonably foreseen. GS1 US reserves the right to change the material at any time.